Practical Guides

Q: What if the person does not want treatment?

Refusal at the first attempt is the normal outcome rather than the end of it. In randomised trials, teaching the family member behaviour-change skills engaged 64% of initially unmotivated people, against 30% for a confrontational family meeting.

Q: Will going to treatment cost someone their job?

FMLA leave may be taken for treatment by a health care provider, though absence because of using the substance does not qualify, and an employer policy that predates the leave can still operate.

The hardest questions about addiction treatment usually come before anyone reaches a clinician: how to raise it with someone who does not want to hear it, how to afford it, what happens once the doors close. These guides answer those, with sources you can check.

Every guide

How to Get Someone Into Rehab
You usually cannot force an adult into addiction treatment. What works is removing the obstacles, picking the moment, and knowing the legal exceptions.
Arrange the bed before you raise it: the most common failure is getting a yes and losing it to a two-week wait
Paying for Rehab Without Insurance
State-funded programmes, sliding-scale fees, federal block grants and payment plans. What each option actually is, who qualifies, and how to reach it.
91.6% of facilities accept self-payment: and the published price is frequently not the price people end up paying
Rehab Rules: What You Can and Cannot Do in Treatment
What treatment facilities restrict and why: phones, visitors, relationships, leaving early. Rules vary by level of care, so here is what to ask first.
Rules exist to remove decisions, not to punish: they concentrate where relapse risk is highest — phones, visitors, leaving the site
Suboxone Withdrawal Timeline: Why It Starts Late and Lasts Longer
Why buprenorphine withdrawal is delayed, what the FDA label says about tapering, and our count of how many US facilities will actually help you come off.
Half-life 24 to 42 hours: from the FDA label. Withdrawal is delayed because the drug is still there, not because nothing is happening
7-OH Withdrawal Timeline: What It Is and Why Stopping Is Hard
What 7-hydroxymitragynine actually is, why withdrawal behaves like an opioid, and what the Federal Register says about the ban as of September 2026.
It is not leaf kratom: 7-OH is present in the leaf only in trace amounts. The products sold are enriched or semi-synthetic, made by oxidising mitragynine
Meth Withdrawal Timeline: What the Evidence Actually Says
Where the 7-to-10-day figure comes from, why NIDA and the original study disagree, and our count of how few US facilities offer stimulant detox.
The peak is disputed: NIDA says 2 to 3 days after last use; the 2005 Addiction study found the peak inside the first 24 hours
Cocaine Withdrawal Timeline: What the Days Actually Look Like
The crash, the weeks after, and why the withdrawal is not the dangerous part. With our own count of which treatments US facilities actually offer.
The crash begins almost immediately: not after a delay, as with opioids: the clinical description is that it follows the end of use or a binge straight away
Opioid Withdrawal Timeline: What Happens, and When
Symptoms start around 12 hours after short-acting opioids and 30 after methadone. Fentanyl changes the picture, and the real danger comes after it ends.
Onset: about 12 hours after heroin, 30 after methadone: the longer the opioid acts, the later withdrawal starts and the longer it runs
Relapse Warning Signs: What Comes Before Using Again
Relapse starts weeks before anyone picks anything up. The published model names three stages, and the early one has no thoughts of using in it at all.
The first stage contains no thoughts of using: which is exactly why it is missed — and why it is the stage where intervention works best
Rehab for Professionals: What Is Actually Different
Licensed professionals get the best documented outcomes, and the most monitoring. What that trade involves, state by state.
78.7% licensed and working at five years: from a cohort of 904 physicians across 16 state programmes: the best documented outcomes in the field
What Happens in Rehab: The Day, the Week, the Month
Admission day is paperwork, not therapy. Most of the rest is group work. An honest account of the schedule, the therapies by name and the emotional arc.
Day one is administrative, not therapeutic: assessment, medical history, consent forms and a search of belongings, that is expected, not a bad sign
Court-Ordered Rehab: How It Works and What the Evidence Shows
A judge can order treatment by several routes, each with different consequences. Drug court, civil commitment and what each means.
Which route you are on decides the stakes: diversion can end in dismissal; a probation condition means failing is a violation
Sober Living Rules: What They Are and What Is Enforceable
Abstinence, testing, curfew, chores and rent are near-universal. What is negotiable, what the law protects, how to spot a bad house.
The core rules are near-universal: abstinence, testing, curfew, chores, meetings, rent and employment — expect all of these
How Long Does Suboxone Stay in Your System?
Buprenorphine has a 24 to 42 hour half-life. Urine tests find it for about a week, hair for months, and the blocking effect fades sooner than the drug does.
Half-life is 24 to 42 hours: the FDA label figure: the 2 to 4 hours printed on some test-kit inserts is an outdated distribution-phase number

Bar chart of how many US treatment facilities offer each level of care: outpatient 85.4%, residential 21.4%, medical detox 19.5%, hospital inpatient 5.9% — Outpatient care is nearly universal; residential and detox are the scarce tiers. That scarcity is part of why they cost what they do and why waits exist.

Bar chart of payment types accepted by US addiction treatment facilities: cash 91.6%, private insurance 80.7%, Medicaid 83.4%, Medicare 55.2%, state-financed 54.5%, military 49.6%, sliding scale 40.0%, payment assistance 22.5% — Accepting your insurer is not the same as your plan covering the level of care you need. The two questions have to be asked separately.

Which guide answers your situation

These three cover the questions that come before anyone reaches a clinician, and they are usually needed in a specific order rather than all at once.

The person has not agreed yet

Getting someone into treatment covers what the randomised trials actually found about interventions, what involuntary commitment does and does not achieve, and the finding families are rarely told: every approach tested improved the family member’s own wellbeing, whether or not the other person agreed.

Money is the obstacle

Paying without insurance sets out the routes in the order that changes the number, and the federal rules that give pregnant women and people who inject drugs admission deadlines rather than a place in a queue.

Admission is arranged and the worry is what happens next

Rules once you are there covers phones, visitors, leaving early and what happens to a job \u2014 including the precise boundary federal leave law draws between treatment and use.

Bar chart of medication for opioid use disorder availability: buprenorphine at 59.2% of facilities, methadone at 13.7%, certified opioid treatment programmes at 12.8% — The four-to-one gap between buprenorphine and methadone availability is a regulatory fact, not a clinical judgement about which works better.

Bar chart of dedicated programming reported by US treatment facilities for older adults, women, men, trauma-informed care, criminal justice referrals, adolescents, veterans, pregnant women and Spanish-language services — Coverage is wider than most people assume. It is worth asking rather than ruling a programme out on the assumption it will not fit.

Three figures: 69.5% of facilities treat co-occurring disorders, 59.8% offer trauma-informed care, 19.5% run medical detox — Co-occurring capability is self-reported. Ask what it means concretely, which clinicians are on staff, and whether psychiatric medication can be prescribed and reviewed on site.

Bar chart comparing the share of facilities using a sliding fee scale across the nine largest US states, from 23% in North Carolina to 57% in Illinois — A national average is a poor guide to your own options. The same question — can I pay less than the sticker price? — gets a very different answer by state.

What the national picture looks like

Our own count of the federal treatment directory, because these guides are only useful if what they describe is actually reachable.

Availability

85.4% of facilities offer outpatient treatment and 21.4% offer residential care. Where a wait for a bed is the obstacle, an outpatient start is usually available in the meantime.

Paying

83.4% accept Medicaid, 54.5% take state funding outside it, and 40% run a sliding fee scale.

Specific groups

42.7% run adolescent programmes, 39.2% serve veterans and 38% serve pregnant and postpartum women \u2014 wider coverage than most people assume before asking.

Questions these guides answer

What if the person does not want treatment?

Refusal at a first attempt is the normal outcome rather than the end of it. In randomised trials, teaching the family member behaviour-change skills engaged 64% of initially unmotivated people, against 30% for a confrontational family meeting and 13% for Al-Anon facilitation.

What if there is no money and no insurance?

Federal block grant rules give some people admission deadlines rather than a place in a queue, and 40% of facilities operate a sliding fee scale that is almost never volunteered unless asked for by name.

Will going to treatment cost someone their job?

Federal leave law may cover the treatment, though absence because of using the substance does not qualify, and an employer policy that predates the leave can still operate. The distinction is precise and it is set out in the rules guide.

Will a medication show up on a drug test, and for how long?

Buprenorphine has a 24 to 42 hour half-life and stays in urine for about a week after daily treatment, yet the federal and DOT panels do not test for it at all. The Suboxone detection guide separates how long it is detectable from how long it keeps working, which is the gap that matters for safety.

Bar chart comparing Medicaid acceptance among treatment facilities in the nine largest US states — Where the share is low, the reason is usually how the state runs its programme rather than reluctance among facilities.

Bar chart comparing the share of each state’s facilities offering residential treatment across the nine largest US states — Residential beds are unevenly distributed. In some states the search will realistically cross state lines.

Diagram of the step-down pathway through addiction treatment: detox, residential, partial hospitalisation, intensive outpatient, then outpatient and aftercare — Nobody needs every step. The ladder exists so that support can be reduced as stability improves, not so that everyone starts at the top.

Checklist of the six ASAM assessment dimensions: withdrawal risk, medical conditions, emotional and behavioural conditions, readiness to change, relapse potential, and recovery environment — This is the framework US programmes and insurers actually use. The sixth dimension — what home is like — is the one families most often underestimate.

Checklist of six questions to ask a treatment facility about network status, prior authorisation, all-in cost, medication availability, aftercare and accreditation — How plainly a programme answers these is itself information about how it operates.

Table showing when to call 911, 988 or the SAMHSA National Helpline for overdose, immediate danger, suicidal thoughts, severe distress and treatment questions — All three are free and staffed around the clock. 988 is the Suicide & Crisis Lifeline; the SAMHSA National Helpline is 1-800-662-4357.

Three things worth knowing before you start

Each of these comes up across all three guides, and each is the kind of fact that changes a decision rather than merely informing it.

Willingness is a narrow window

The most common failure is getting a yes and losing it to a two-week wait for a bed. Arranging the placement before the conversation is not over-preparation; it is the difference between an agreement and an admission.

Records are protected more tightly than you expect

Treatment records held by a federally assisted programme fall under confidentiality rules stricter than HIPAA, and disclosure generally needs written consent. That matters for employers, for courts and for family, in both directions, since it also means nobody learns you are in treatment unless you authorise it.

The period after treatment is the risky one

Tolerance falls during any period of abstinence, which is why the days after leaving a programme carry more overdose risk than the days before entering one. Where opioids are involved, naloxone at home is a concrete step that does not depend on anything else being arranged.

What these guides deliberately do not do

Much of this sector is paid per admission, and that shapes what its pages say. These earn nothing either way, which is why they can recommend the cheaper level of care when it is the right one, and why the following are absent by policy rather than by oversight.

No phone number of ours

A prominent number on a page like this usually routes to a call centre paid per admission. The numbers here are federal helplines: 988 and the SAMHSA National Helpline, and they reach nobody connected to us.

No facility recommendations

We do not maintain a list of best centres, because we have no defensible basis for ranking one against another and the sites that do usually have a commercial one. What we publish instead is what to ask any programme, and what its answers tell you.

No urgency, and no unsourced statistics

No countdown timers, no beds-available-now, no success rates we cannot source. Where a figure varies by state, plan or facility, these guides say so rather than publishing an average that reads as a fact about your situation.

No clinician’s name we did not earn

No doctor reviews this site and we do not claim otherwise. These pages report what public clinical sources say and show you where to read them, which is a different thing from clinical advice and is described as such throughout.

No data we cannot show you

Every proportion quoted here is our own count of the federal directory, with the method published so it can be repeated. If a figure appears without a source, treat that as an error and tell us.

Compare the options themselves

Sources used across these guides

How this page was made

Who wrote it:: the Treatment Compass editorial team : researchers and writers, not clinicians. No doctor has reviewed this page, and we do not claim otherwise. What that means in practice: we report what public clinical sources say and show you where to read them, rather than offering a clinical opinion of our own.
Checked against:: 6 primary sources listed above: federal agency material and published clinical criteria. Where a figure varies by state, plan or facility, we say so instead of publishing a number that looks authoritative and is not.
Original analysis:: the facility proportions on this page are our own count of SAMHSA’s public directory. The full method is documented , including what we count, what we deliberately do not publish, and an error the approach caught. You can repeat the pull and check the numbers.
Last reviewed:: August 25, 2026. This date changes when the content is actually re-checked, not automatically on every visit.
What this page is not:: a medical recommendation, a diagnosis, or a referral. Decisions about levels of care and medication belong with a clinician who knows your history. We do not operate facilities, take placement fees, or receive payment for sending anyone anywhere.

Deciding between levels of care? See our comparisons and insurance explainers.

Information, not medical advice. If you are in crisis, call or text 988 in the US, or reach the SAMHSA National Helpline at 1-800-662-4357 — free, confidential, 24/7.